期刊
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
卷 25, 期 6, 页码 1066-1071出版社
WILEY
DOI: 10.1111/j.1440-1746.2010.06280.x
关键词
esophageal peristaltic contraction; gastroesophageal reflux; impedance monitoring; lower esophageal sphincter; saliva
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan [19590724]
- Grants-in-Aid for Scientific Research [19590724] Funding Source: KAKEN
Background and Aim: A substantial number of patients with gastroesophageal reflux disease show symptomatic resistance to high-dose proton pump inhibitors. In those cases, prokinetics are possible candidates for treatment. The aim of the present study was to determine whether mosapride, a prokinetic agent, stimulates esophageal functions, and prevents acidic and non-acidic gastroesophageal reflux. Methods: Normal volunteers (nine and 13 for two experiments, respectively) were enrolled. Salivary secretion, esophageal peristaltic contractions, and resting lower esophageal sphincter pressure with and without mosapride administration were recorded using a cross-over protocol. Post-prandial acidic and non-acidic reflux levels were also recorded. Results: Mosapride at a standard dose of 15 mg/day did not stimulate salivary secretion or any esophageal motor functions. It also failed to prevent acidic and non-acidic post-prandial gastroesophageal reflux. Conclusions: Mosapride at 15 mg/day, a standard dose in Japan, did not change the esophageal motility and salivary secretion in healthy volunteers. Future study on a larger number of individuals with higher dose of mosapride is worthwhile.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据